Recall · openFDA Food Enforcement

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24…: FDA Recall F-0463-2024

Agency action: Sep 28, 2023Record ID: F-0463-2024
View official source ↗

What happened

Original notice title

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104., recall F-0463-2024

From the archived source record

FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Terminated
FDA recall classification
Class III
Recall initiated by
Voluntary: Firm initiated
Report date
Nov 29, 2023
Termination date in the archive
Jan 16, 2024
Source checked
Jul 16, 2026
Record revision
8ca4fb7d6488

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
Company
ActiPharma, Inc.
Lot / identifier
Lot 13309, Exp: 01/26
Market / distribution
Domestic distribution, in Puerto Rico.